CXCL8 and Hepatic fibrosis: We have previously identified several biomarkers of disease severity and prognosis in PSC reflecting different aspects of the disease process, like inflammation (IL-8)9, neutrophil activation (soluble CD14)10, fibrosis (enhanced liver fibrosis [ELF] score and pro-C3)11 and gut microbial activity12,13.